$235 million announced for expansion of biotech sector at CSL

A $235 million expansion of Australia's largest biotech facility in Melbourne is planned and this is expected to create hundreds of jobs. CSL biopharmaceutical research complex in Broadmeadows, in the north of Melbourne will be receiving this financial aid from both the State as well as Federal government over a five year investment plan. This will create an estimated 320 temporary construction jobs and later 333 new highly-skilled medical research openings by 2018.

At present CSL focuses on vaccine development but with the fresh funds more avenues of research like in cancer, blood related diseases, infections and inflammation as well as drug development and clinical trials, are expected to open up. CSL group has branches in 27 countries globally. CSL chief executive Brian McNamee feels that many life saving therapies can now be developed here. In a statement he said, “It will enable us to do important clinical development on a number of large projects that we're working on in the fields of cancer, hematology, inflammation, and these are long term investments.”

Premier John Brumby after announcing the release of funds said, “Victoria has earned itself a reputation as a biotech hub of the Asia-Pacific and we are well on the way to becoming one of the world's top five biotech destinations…CSL's expansion will be important in driving our biotech excellence and is a vote of confidence in our state's investment attraction capabilities.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). $235 million announced for expansion of biotech sector at CSL. News-Medical. Retrieved on December 09, 2019 from https://www.news-medical.net/news/20100715/24235-million-announced-for-expansion-of-biotech-sector-at-CSL.aspx.

  • MLA

    Mandal, Ananya. "$235 million announced for expansion of biotech sector at CSL". News-Medical. 09 December 2019. <https://www.news-medical.net/news/20100715/24235-million-announced-for-expansion-of-biotech-sector-at-CSL.aspx>.

  • Chicago

    Mandal, Ananya. "$235 million announced for expansion of biotech sector at CSL". News-Medical. https://www.news-medical.net/news/20100715/24235-million-announced-for-expansion-of-biotech-sector-at-CSL.aspx. (accessed December 09, 2019).

  • Harvard

    Mandal, Ananya. 2018. $235 million announced for expansion of biotech sector at CSL. News-Medical, viewed 09 December 2019, https://www.news-medical.net/news/20100715/24235-million-announced-for-expansion-of-biotech-sector-at-CSL.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Mount Sinai receives $1 million grant to advance understanding of prostate cancer